Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
Sign in with Google
bullish
China Industrials
China Infrastructure REITs: Excellent First Batch Result - Good for Zhejiang Expressway (576 HK)
Thematic (Sector/Industry)
425 Views
04 Jun 2021 00:48
Good response to the first batch of China public infrastructure REIT issuance indicates investor demand, and this is positive to Zhejiang Exp, CCCC, Shenzhen Intl, Sinotrans and China Everbright Env.
SUMMARY
(Sign Up to Access)
Full Insight
(Paid Plans Only, 3-minute read)
Related Insights
More »
Loading
Trending Collections
More »
Event-Driven
Index Rebalance
Equity Derivatives
Equity Bottom-Up
South Korea
India
Japan
Philippines
Asia ECM
Hong Kong
Trending Insights
More »
[Japan M&A] Toyota Inds (6201) Proposed Takeover - It Looks Bad, and It's Worse Than It Looks
Mayne Pharma (MYX AU): Twists and Turns as Cosette Chases a Get-Out-Of-Jail-Free Card
US vs EU: Mutually Assured Destruction?
Toyota Motor (7203 JP) Outlook Amid Uncertainty Over Toyota Industries Privatization Bid
TIP Customized Taiwan Select High Dividend Index Rebalance: 22 Changes as Expected
Top Unpaywalled Insights
More »
VEON US: Pakistan Towers Sale Frees Capital for Digital Growth in Core Market Ahead of Ukraine IPO
Advanced Look: Navigating the New Macro Landscape Through Quantitative Alpha Generation Strategies
[IO Technicals 2025/22] Bearish Momentum Strengthens
Texas Power Play: Grid Sovereignty, Bitcoin, and the Future of AI
Overview #27 – The Big Beautiful Tragi-Comedy Continues
Discussions
(Paid Plans Only)
Insight Stream
CSI REITs Index: An Investable Benchmark Launches Today
14 Dec 2022
Zhejiang Expressway (576 HK): Reversion to Growth and Kick-Off of REIT Are Clear Positives
06 May 2021
Sinotrans (598 HK): A REIT Perspective
14 Sep 2020
China Infrastructure REITs: First Look on H-Share Toll Road Sector
11 Jun 2020
Top
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.53.3
x